Diagnosing polymyalgia rheumatica can be complicated, because its symptoms overlap with those of several other conditions. Learn which other diseases your doctor may have to rule out.

Corticosteroids are the mainstay of treatment for polymyalgia rheumatica, but there are other drug options, and physical activity can help, too. Polymyalgia Rheumatica Treatment: Medications ...

Polymyalgia rheumatica and giant cell arteritis PMR is closely linked with an autoimmune disease called giant cell arteritis (GCA), which is an inflammatory condition affecting the arteries.

Sparrow Pharmaceuticals Expands Phase 2 Clinical Trial of SPI-62 with Prednisolone for Polymyalgia Rheumatica with ... sleeplessness, osteoporosis (bone loss), glaucoma, thinning of the skin, and ...

Polymyalgia rheumatica is occasionally accompanied by sudden blindness ensuing upon relatively ... P. D. C., and McCallum, D. I. Skin manifestations of giant-cell arteritis. Brit. J. Dermal. 76: ...

ANSWER: Polymyalgia rheumatica (PMR) is not an uncommon disease, yet I find that many people haven’t heard of it. It’s a disease that is most common in people in their 70s, more common in ...

BARCELONA, Spain — Compared with placebo, adding methotrexate (MTX) to treatment for newly diagnosed polymyalgia rheumatica (PMR) nearly doubled glucocorticoid (GC)-free remission rates at 1 ...

Polymyalgia rheumatica (PMR) is a systemic inflammatory disorder that predominantly affects individuals over the age of 50. It is characterised by pain and stiffness in the shoulder and hip ...

Kevzara ® (sarilumab) approved by FDA as first and only biologic indicated for patients with polymyalgia rheumatica. News release. Sanofi-aventis. February 28, 2023. Accessed March 1, 2023.

Polymyalgia rheumatica--or PMR-- is a rare autoimmune disease most often found in older women of European descent. PMR is an inflammatory condition causing stiffness and muscle pain.

Sparrow Pharmaceuticals Expands Phase 2 Clinical Trial of SPI-62 with Prednisolone for Polymyalgia Rheumatica with Second Cohort. March 08, 2023 08:00 AM Eastern Standard Time. ... muscle, and skin.